AlloVir ALVR
$ 0.54
-5.42%
Quarterly report 2024-Q3
added 11-12-2024
AlloVir Balance Sheet 2011-2024 | ALVR
Annual Balance Sheet AlloVir
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-62.7 M | -70.7 M | -172 M | -114 M | -49.3 M | -22.2 M | - | - | - | - | - | - | - |
Long Term Debt |
16.6 M | 28.2 M | 23.5 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
10.8 M | 7.16 M | 6.59 M | 3.23 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 5.46 M | 182 M | 52.2 M | - | - | - | - | - | - | - |
Total Current Liabilities |
28.4 M | 24.3 M | 37.9 M | 12.3 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
45 M | 52.6 M | 61.3 M | 17.8 M | 191 M | 55.9 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | 2.66 M | - | - | - | - | - | - | - |
Retained Earnings |
-656 M | -466 M | -297 M | -125 M | -55.3 M | -31.5 M | - | - | - | - | - | - | - |
Total Assets |
191 M | 277 M | 287 M | 371 M | 139 M | 25.3 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
90.1 M | 106 M | 202 M | 123 M | - | - | - | - | - | - | - | - | - |
Book Value |
146 M | 225 M | 225 M | 353 M | -51.5 M | -30.6 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
146 M | 225 M | 225 M | 353 M | -51.5 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet AlloVir
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 8.34 M | 16 M | 16.6 M | 19.9 M | 23 M | 25.6 M | 28.2 M | 19.8 M | - | 20.8 M | 23.5 M | 25.1 M | 4.33 M | 5.41 M | 5.46 M | 5.46 M | 5.46 M | 5.46 M | 8.69 M | 8.69 M | 8.69 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.41 M | 10.7 M | 23.7 M | 45 M | 53 M | 53.6 M | 50.5 M | 52.6 M | 40.5 M | - | 39.4 M | 61.3 M | 49.2 M | 25 M | 20.9 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-697 M | -693 M | -686 M | -656 M | -596 M | -552 M | -507 M | -466 M | -428 M | - | -341 M | -297 M | -239 M | -194 M | -156 M | -125 M | -125 M | -125 M | -125 M | -55.3 M | -55.3 M | -55.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
123 M | 131 M | 144 M | 191 M | 248 M | 283 M | 244 M | 277 M | 294 M | - | 231 M | 287 M | 317 M | 328 M | 351 M | 371 M | 371 M | 371 M | 371 M | 139 M | 139 M | 139 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
117 M | 105 M | 86 M | 90.1 M | 95.6 M | 197 M | 116 M | 106 M | 124 M | 71.1 M | 100 M | 202 M | 243 M | 225 M | 169 M | 123 M | 123 M | 123 M | 123 M | 61.1 M | 61.1 M | 61.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
121 M | 120 M | 120 M | 146 M | 195 M | 229 M | 194 M | 225 M | 253 M | - | 192 M | 225 M | 267 M | 302 M | 330 M | 353 M | 353 M | 353 M | 353 M | 122 M | 122 M | 122 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
121 M | 120 M | 120 M | 146 M | 195 M | 229 M | 194 M | 225 M | 253 M | 158 M | 192 M | 225 M | 267 M | 302 M | 330 M | 353 M | 353 M | 353 M | 353 M | -51.5 M | -51.5 M | -51.5 M | -32.9 M | -30.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency